The effect of locoregional therapies in patients with advanced hepatocellular carcinoma treated with sorafenib

BACKGROUND & AIMS: It is unknown whether the addition of locoregional therapies (LRTx) to sorafenib improves prognosis over sorafenib alone in patients with advanced hepatocellular carcinoma (HCC). The aim of this study was to assess the effect of LRTx in this population. METHODS: A retrospectiv...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:HPB (Oxford)
Hauptverfasser: Sarpel, Umut, Spivack, John H., Berger, Yaniv, Heskel, Marina, Aycart, Samantha N., Sweeney, Robert, Edwards, Martin P., Labow, Daniel M., Kim, Edward
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2016
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4857060/
https://ncbi.nlm.nih.gov/pubmed/27154804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hpb.2016.02.007
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge